{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T12:53:20Z","timestamp":1679316800408},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.rmr.2015.12.010","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T14:45:34Z","timestamp":1458053134000},"page":"607-611","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pleur\u00e9sie induite par l\u2019atorvastatine"],"prefix":"10.1016","volume":"33","author":[{"given":"Y.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Gourdier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gagnadoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Trzepizur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2015.12.010_bib0075","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013\u00a0ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmr.2015.12.010_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials","volume":"278","author":"Hebert","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2015.12.010_bib0085","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1136\/bmj.g3743","article-title":"Non-cardiovascular effects associated with statins","volume":"349","author":"Desai","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2015.12.010_bib0090","doi-asserted-by":"crossref","first-page":"f880","DOI":"10.1136\/bmj.f880","article-title":"Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases","volume":"346","author":"Dormuth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2015.12.010_bib0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2015.12.010_bib0100","first-page":"246","article-title":"Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry","volume":"106","author":"Perdices","year":"2014","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.rmr.2015.12.010_bib0105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports","volume":"134","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2015.12.010_bib0135","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1378\/chest.115.3.886","article-title":"Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases","volume":"115","author":"Liebhaber","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2015.12.010_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/j.1326-5377.2007.tb00809.x","article-title":"Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease","volume":"186","author":"Walker","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.rmr.2015.12.010_bib0115","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1183\/09031936.00087007","article-title":"Bilateral pleural effusions associated with pravastatin sodium treatment","volume":"30","author":"Kalomenidis","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2015.12.010_bib0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2796.1996.411762000.x","article-title":"Interstitial lung disease with pleural effusion caused by simvastin","volume":"239","author":"De Groot","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.rmr.2015.12.010_bib0125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejim.2006.02.011","article-title":"Eosinophilic pleural effusion caused by simvastatin after 13\u00a0years of exposure","volume":"17","author":"Roncato-Sab\u00e9ran","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rmr.2015.12.010_bib0130","first-page":"426","article-title":"Une pneumopathie iatrog\u00e8ne rapport\u00e9e \u00e0 la prise de pravastatine","volume":"18","author":"Lisco\u00ebt-Loheac","year":"2001","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2015.12.010_bib0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1183\/09031936.02.00258802","article-title":"Statin-induced fibrotic nonspecific interstitial pneumonia","volume":"19","author":"Lantuejoul","year":"2002","journal-title":"Eur Respir J"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842516000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842516000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:45:22Z","timestamp":1655268322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842516000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0761842516000541"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2015.12.010","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleur\u00e9sie induite par l\u2019atorvastatine","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2015.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}